76-90 of 282
Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Project Oncology®Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Alexis Leonard
Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Project Oncology®Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Recognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Clinician's RoundtableRecognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Ryan Quigley
Enhancing IgAN Care: The Importance of a Proactive Approach
Clinician's RoundtableEnhancing IgAN Care: The Importance of a Proactive Approach
Gates B. Colbert, MD
Suneel Udani, MD
Navigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Clinician's RoundtableNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Barratt, MD, PhD
Shikha Wadhwani, MD
Deciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Clinician's RoundtableDeciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Gates B. Colbert, MD
Jonathan Barratt, MD, PhD
- advertisement
Innovations in IgAN Care: Addressing Challenges with Therapeutic Advances
Clinician's RoundtableInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
Charles Turck, PharmD, BCPS, BCCCP
Pietro A. Canetta, MD
Moving Beyond Immunosuppressive Therapy in IgAN
Clinician's RoundtableMoving Beyond Immunosuppressive Therapy in IgAN
Gates B. Colbert, MD
Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Project Oncology®Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Charles Turck, PharmD, BCPS, BCCCP
Jonathon B. Cohen, MD, MS
Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Project Oncology®Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Ashley Baker, MSN, PMHNP
Alyssa Schlenz
Shannon Phillps
Differentiating and Diagnosing Sjögren’s-Related Dry Eye
Living RheumDifferentiating and Diagnosing Sjögren’s-Related Dry Eye
Michelle Hessen, OD
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Living RheumSjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Michelle Hessen, OD
- advertisement
Targeting CD19 in Autoimmune Neuropathy: Case Report Insights
Living RheumTargeting CD19 in Autoimmune Neuropathy: Case Report Insights
Reimagining Autoimmune Care with CAR-Based Cell Therapies
Living RheumReimagining Autoimmune Care with CAR-Based Cell Therapies
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Project Oncology®Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Marlene Mimi Maeusli, PhD.
